MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study by Rui Bergantim, Rui Bergantim, Rui Bergantim, Rui Bergantim, Sara Peixoto da Silva, Sara Peixoto da Silva, Sara Peixoto da Silva, Vanessa Pinto, Vanessa Pinto, Joana M. Pereira, Joana M. Pereira, Diana Sousa, Diana Sousa, Diana Sousa, Fernanda Trigo, Rune Matthiesen, José E. Guimarães, José E. Guimarães, José E. Guimarães, José E. Guimarães, José E. Guimarães, M. Helena Vasconcelos, M. Helena Vasconcelos, M. Helena Vasconcelos

Get full text

Challenges in the preclinical design and assessment of CAR-T cells by Radu Tomai, Radu Tomai, Javier De Las Rivas, Bogdan Fetica, Bogdan Fetica, Rui Bergantim, Rui Bergantim, Rui Bergantim, Rui Bergantim, Brankica Filipic, Zarko Gagic, Katarina Nikolic, Diana Gulei, Diana Gulei, David Kegyes, David Kegyes, Madalina Nistor, Madalina Nistor, Ximena Maria Muresan, Ximena Maria Muresan, Diana Cenariu, Diana Cenariu, Richard Feder, Richard Feder, Mariana Pavel-Tanasa, Andrei Cianga, Adrian Bogdan Tigu, Adrian Bogdan Tigu, Raluca Munteanu, Raluca Munteanu, Alina Tanase, Hermann Einsele, Hermann Einsele, Hermann Einsele, Ciprian Tomuleasa, Ciprian Tomuleasa

Get full text

The evolving treatment landscape of multiple myeloma in Portugal: A nation‐wide retrospective cohort study of real‐world clinical practice by Rui Bergantim, Catarina Geraldes, Cristina João, Paulo Lúcio, Manuel Neves, Fernanda Trigo, Hugo Pedrosa, Miguel Ventura, Susana Santos, Diogo Ramos

Get full text